Hydropearl
Payments companies reported to CMS as associated with Hydropearl. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Hydropearl, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Hydropearl
These are the largest totals companies reported as associated with Hydropearl. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| William Julien | Coconut Creek, FL | Vascular & Interventional Radiology | $7,378.27 |
| Ghassan El Haddad | Tampa, FL | Vascular & Interventional Radiology | $5,561.79 |
| Adam Alli | Houston, TX | Vascular & Interventional Radiology | $5,060.81 |
| Siddharth Padia | Los Angeles, CA | Vascular & Interventional Radiology | $4,549.85 |
| Riad Salem | Chicago, IL | Vascular & Interventional Radiology | $3,850.00 |
| Erika Ugianskis | Lafayette, IN | Vascular & Interventional Radiology | $3,600.00 |
| Marcelo Guimaraes | Charleston, SC | Vascular & Interventional Radiology | $3,553.15 |
| Margaret Tempero | San Francisco, CA | Internal Medicine | $3,300.00 |
| Anthony El-Khoueiry | Los Angeles, CA | Medical Oncology | $3,025.00 |
| Sandeep Bagla | Falls Church, VA | Vascular & Interventional Radiology | $2,574.09 |
Prescribed Hydropearl?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.